Cited by 516Regulation of Appetite and ObesityNeurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake

Open access

Alhadeff, Amber L., Rupprecht, Laura E., Hayes, Matthew R.·2012·Endocrinology

DOI 10.1210/en.2011-1443PMC PMC3275387

Open this paper in CoChat — free account Open PDF

Abstract

Central glucagon-like-peptide-1 (GLP-1) receptor activation reduces food intake; however, brain nuclei and mechanism(s) mediating this effect remain poorly understood. Although central nervous system GLP-1 is produced almost exclusively in the nucleus of the solitary tract in the hindbrain, GLP-1 receptors (GLP-1R) are expressed throughout the brain, including nuclei in the mesolimbic reward system (MRS), e.g. the ventral tegmental area (VTA) and the nucleus accumbens (NAc). Here, we examine the MRS as a potential site of action for GLP-1-mediated control of food intake and body weight. Double immunohistochemistry for Fluorogold (monosynaptic retrograde tracer) and GLP-1 neuron immunoreactivity indicated that GLP-1-producing nucleus tractus solitarius neurons project directly to the VTA, the NAc core, and the NAc shell. Pharmacological data showed that GLP-1R activation in the VTA, NAc core, and NAc shell decreased food intake, especially of highly-palatable foods, and body weight. Moreover, blockade of endogenous GLP-1R signaling in the VTA and NAc core resulted in a significant increase in food intake, establishing a physiological relevance for GLP-1 signaling in the MRS. Current data highlight these nuclei within the MRS as novel sites for GLP-1R-mediated control of food intake and body weight.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/en.2011-1443

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503
Effects of exenatide (Exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Neurobiology of addiction
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Conditioned Aversion to Saccharin Resulting from Exposure to Gamma Radiation
García, J., Kimeldorf, D. J., & Koelling, R. A. (1955) · Science · doi:10.1126/science.122.3160.157 · Cited by 1,011
Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding
Hommel, J. D., Trinko, R., Sears, R. M., Georgescu, D., Liu, Z.-W., Gao, X.-B., Thurmon, J. J., Marinelli, M., & DiLeone, R. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.023 · Cited by 902

Flagged first, then by citations

Show all 69 references

1 of the 69 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Hayes, 2011, Intracellular signals mediating the food intake suppressive effects of hindbrain glucagon-like-peptide-1 receptor activation., Cell Metab, 13, 320, 10.1016/j.cmet.2011.02.001 · DOI

Sorted by citations

Items 201–300 of 516

The emerging role of glucagon-like peptide 1 in binge eating
Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0405 · Cited by 38
GLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract
Card, J. P., Johnson, A. L., Llewellyn‐Smith, I. J., Zheng, H., Anand, R., Brierley, D. I., Trapp, S., & Rinaman, L. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24482 · Cited by 38
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
Falk, S., Petersen, J., Svendsen, C., Leguizamón, C. R. R., Jørgensen, S. H., Krauth, N., Ludwig, M. Q., Lundø, K., Roostalu, U., Skovbjerg, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112466 · Cited by 38
Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders
Keel, P. K., Bodell, L. P., Forney, K. J., Appelbaum, J., & Williams, D. L. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112565 · Cited by 38
Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent
Jensen, M. E., Galli, A., Thomsen, M., Jensen, K. L., Thomsen, G. K., Klausen, M. K., Vilsbøll, T., Christensen, M., Holst, J. J., Owens, A. W., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104772 · Cited by 42
Glucagon‐Like Peptide‐1 Receptor Signaling in the Ventral Tegmental Area Reduces Alcohol Self‐Administration in Male Rats
Dixon, T. N., McNally, G. P., & Ong, Z. Y. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14437 · Cited by 38
Gut peptide regulation of food intake - evidence for the modulation of hedonic feeding.
Woodward, O. R. M., Gribble, F. M., Reimann, F. M., & Lewis, J. E. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.74301 · Cited by 38
Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats
Urbanik, L. A., Acharya, N., & Grigson, P. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.023 · Cited by 39
High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats
Mul, J. D., Begg, D. P., Barrera, J. G., Li, B., Matter, E. K., D’Alessio, D. A., Woods, S. C., Seeley, R. J., & Sandoval, D. A. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00588.2012 · Cited by 38
Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt
Rupprecht, L. E., Mietlicki‐Baase, E. G., Zimmer, D. J., McGrath, L. E., Olivos, D. R., & Hayes, M. R. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00367.2013 · Cited by 37
Self-citation
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats
Evans, B., Stoltzfus, B., Acharya, N., Nyland, J. E., Arnold, A. C., Freet, C. S., Bunce, S. C., & Grigson, P. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.022 · Cited by 39
Metformin and the Liver: Unlocking the Full Therapeutic Potential
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D’Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., et al. (2024) · Metabolites · doi:10.3390/metabo14040186 · Cited by 39
Distribution of glucagon-like peptide 1-immunopositive neurons in human caudal medulla
Zheng, H., Cai, L., & Rinaman, L. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0714-z · Cited by 36
Long‐acting glucagon‐like peptide‐1 receptor agonists have direct access to and effects on pro‐opiomelanocortin/cocaine‐ and amphetamine‐stimulated transcript neurons in the mouse hypothalamus
Knudsen, L. B., Secher, A., Hecksher‐Sørensen, J., & Pyke, C. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12463 · Cited by 38
Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones
Ahmed∥, M., & Ahmed, S. (2019) · Gastroenterology Research · doi:10.14740/gr1219 · Cited by 36
Development and validation of the Food Noise Questionnaire
Diktas, H. E., Cardel, M. I., Foster, G. D., LeBlanc, M. M., Dickinson, S. L., Ables, E. M., Chen, X., Nathan, R., Shapiro, D., & Martin, C. K. (2025) · Obesity · doi:10.1002/oby.24216 · Cited by 35
Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward
Reddy, I. A., Stanwood, G. D., & Galli, A. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.003 · Cited by 36
Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea
Jonghe, B. C. D., Holland, R. A., Olivos, D. R., Rupprecht, L. E., Kanoski, S. E., & Hayes, M. R. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.10.031 · Cited by 35
Self-citation
Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice.
Allingbjerg, M.-L., Hansen, S. N., Secher, A., & Thomsen, M. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000620 · Cited by 34
Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
Bae, J. H., Choi, H. J., Cho, K. I. K., Kim, L. K., Kwon, J. S., & Cho, Y. M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0018 · Cited by 33
Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin
Tufvesson‐Alm, M., Shevchouk, O. T., & Jerlhag, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1092828 · Cited by 33
Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides
Sekar, R., Wang, L., & Chow, B. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00018 · Cited by 33
Glucagon-Like Peptide-1 (GLP-1) and 5-Hydroxytryptamine 2c (5-HT2c) Receptor Agonists in the Ventral Tegmental Area (VTA) Inhibit Ghrelin-Stimulated Appetitive Reward
Howell, E., Baumgartner, H. M., Zallar, L. J., Selva, J. A., Engel, L., & Currie, P. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040889 · Cited by 33
What is bipolar disorder? A disease model of dysregulated energy expenditure
Mansur, R. B., Lee, Y. L., McIntyre, R. S., & Brietzke, E. M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.006 · Cited by 33
Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy
Milano, W., Biasio, V. D., Munzio, W. D., Foggia, G., & Capasso, A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200515112853 · Cited by 33
Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., & Mallo, F. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2021.12.005 · Cited by 33
Neural and Molecular Mechanisms Involved in Controlling the Quality of Feeding Behavior: Diet Selection and Feeding Patterns
Sasaki, T. (2017) · Nutrients · doi:10.3390/nu9101151 · Cited by 35
Brain Feeding Circuits after Roux-en-Y Gastric Bypass
Hankir, M. K., Seyfried, F., Miras, A. D., & Cowley, M. A. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.01.009 · Cited by 34
The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1
Fortin, S. M., Chen, J. C., Petticord, M. C., Ragozzino, F. J., Peters, J. H., & Hayes, M. R. (2023) · Science Advances · doi:10.1126/sciadv.adh0980 · Cited by 32
Self-citation
Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use
Farokhnia, M., Fede, S. J., Grodin, E. N., Browning, B. D., Crozier, M. E., Schwandt, M. L., Hodgkinson, C. A., Momenan, R., & Leggio, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-17190-3 · Cited by 32
Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial
Shi, L., Zhu, J., Yang, P., Tang, X., Yu, W., Pan, C., Shen, M., Zhu, D., Cheng, J., & Ye, X. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.01.003 · Cited by 31
PC1/3 Deficiency Impacts Pro-opiomelanocortin Processing in Human Embryonic Stem Cell-Derived Hypothalamic Neurons
Wang, L., Sui, L., Panigrahi, S. K., Meece, K., Xin, Y., Kim, J., Gromada, J., Doege, C. A., Wardlaw, S. L., Egli, D. M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.021 · Cited by 33
Intracerebroventricular injection of phoenixin alters feeding behavior and activates nesfatin-1 immunoreactive neurons in rats
Friedrich, T., Schalla, M. A., Scharner, S., Kühne, S. G., Goebel‐Stengel, M., Kobelt, P., Rose, M., & Stengel, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.034 · Cited by 32
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
Albrechtsen, N. J. W., Kuhre, R. E., Deacon, C. F., & Holst, J. J. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.862152 · Cited by 32
Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin
You, Z., Wang, B., Gardner, E. L., & Wise, R. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.11.001 · Cited by 31
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
Kooij, K. L., Koster, D. I., Eeltink, E., Luijendijk, M. C. M., Drost, L., Ducrocq, F., & Adan, R. A. H. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103925 · Cited by 36
Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
Giannakogeorgou, A., & Roden, M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17848 · Cited by 30
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
Wen, S., Nguyen, T., Gong, M., Yuan, X., Wang, C., Jin, J., & Zhou, L. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s312527 · Cited by 34
Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
Li, Y., & Rosenblit, P. D. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1051-2 · Cited by 30
The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour
Williams, D. L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15535 · Cited by 32
Intermittent access to a nutritionally complete high-fat diet attenuates alcohol drinking in rats
Sirohi, S., Cleef, A. V., & Davis, J. F. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.12.009 · Cited by 28
Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?
Roberts, C. A., Christiansen, P., & Halford, J. C. G. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0994-x · Cited by 28
Converging vulnerability factors for compulsive food and drug use
Serafine, K. M., O’Dell, L. E., & Zorrilla, E. P. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108556 · Cited by 29
Peptide and Lipid Modulation of Glutamatergic Afferent Synaptic Transmission in the Solitary Tract Nucleus
Andresen, M. C., Fawley, J. A., & Hofmann, M. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00191 · Cited by 30
Glucagon‐like peptide‐1 drives energy metabolism on the synaptic highway
Liu, J., & Pang, Z. P. (2016) · FEBS Journal · doi:10.1111/febs.13785 · Cited by 27
Hindbrain glucagon-like peptide-1 neurons track intake volume and contribute to injection stress-induced hypophagia in meal-entrained rats
Kreisler, A. D., & Rinaman, L. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00243.2015 · Cited by 27
GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice
Décarie-Spain, L., Fisette, A., Zhu, Z., Yang, B., DiMarchi, R. D., Tschöp, M. H., Finan, B., Fulton, S., & Clemmensen, C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.035 · Cited by 27
Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations
Liang, N.-C., Bello, N. T., & Moran, T. H. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.16 · Cited by 27
Glucagon-like peptide-1 receptors and sexual behaviors in male mice
Vestlund, J., & Jerlhag, E. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104687 · Cited by 31
Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards
Dunigan, A. I., & Roseberry, A. G. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100011 · Cited by 28
Nutritional Controls of Food Reward
Fernandes, M. F., Sharma, S., Hryhorczuk, C., Auguste, S., & Fulton, S. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.04.004 · Cited by 27
GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
Burcelin, R., Gourdy, P., & Dalle, S. (2014) · Physiology · doi:10.1152/physiol.00009.2013 · Cited by 26
The rostromedial zona incerta is involved in attentional processes while adjacent LHA responds to arousal: c-Fos and anatomical evidence
Chometton, S., Charrière, K., Bayer, L., Houdayer, C., Franchi, G., Poncet, F., FELLMANN, D., & Risold, P. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1353-3 · Cited by 29
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
Kokkinos, A. D., Tsilingiris, D., le Roux, C. W., Rubino, F., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153960 · Cited by 28
Mesocortical BDNF signaling mediates antidepressive-like effects of lithium
Liu, D., Tang, Q., Wang, D., Song, S.-P., Yang, X.-N., Hu, S.-W., Wang, Z.-Y., Xu, Z., Liu, H., Yang, J., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0713-0 · Cited by 27
Neuropeptides Modulate Feeding via the Dopamine Reward Pathway
Jin, R., Sun, S., Hu, Y., Zhang, H., & Sun, X. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03954-4 · Cited by 26
Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders
Vadnie, C. A., Park, J. H., Gawad, N. A., Ho, A. M., Hinton, D. J., & Choi, D. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00288 · Cited by 26
Type of sweet flavour carrier affects thyroid axis activity in male rats
Pałkowska-Goździk, E., Bigos, A., & Rosołowska‐Huszcz, D. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1367-x · Cited by 26
Peripheral Vagus Nerve Stimulation Significantly Affects Lipid Composition and Protein Secondary Structure Within Dopamine-Related Brain Regions in Rats
Surówka, A. D., Krygowska‐Wajs, A., Ziomber, A., Thor, P. J., Chrobak, A. A., & Szczerbowska‐Boruchowska, M. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8349-7 · Cited by 24
Control of Appetite and Food Preference by NMDA Receptor and Its Co-Agonist d-Serine
Sasaki, T., Matsui, S., & Kitamura, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071081 · Cited by 27
To Do or Not to Do: Dopamine, Affordability and the Economics of Opportunity
Beeler, J. A., & Mourra, D. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00006 · Cited by 28
Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry
López-Ojeda, W., & Hurley, R. A. (2024) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230226 · Cited by 25
The (dys)regulation of energy storage in obesity
Levin, B. E., Geary, N., & Lutz, T. A. (2025) · Physiological Reviews · doi:10.1152/physrev.00002.2024 · Cited by 27
Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights
Alves, G. A. M., Teranishi, M., Ortega, A. C. T. D. C. G., James, F., & Arachchige, A. S. P. M. (2025) · Medical Sciences · doi:10.3390/medsci13030136 · Cited by 32
The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice
Vestlund, J., & Jerlhag, E. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104778 · Cited by 27
Linking drug and food addiction: an overview of the shared neural circuits and behavioral phenotype
Passeri, A., Municchi, D., Cavalieri, G., Babicola, L., Ventura, R., & Segni, M. D. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1240748 · Cited by 32
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R. F., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 22
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Nicze, M., Dec, A., Borówka, M., Krzyżak, D., Bołdys, A., Bułdak, Ł., & Okopień, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158202 · Cited by 30
Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Klausen, M. K., Knudsen, G. M., Vilsbøll, T., & Fink‐Jensen, A. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70004 · Cited by 26
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 28
Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study
Olbrich, H., Kridin, K., Zirpel, H., Hernández, G., Sadik, C. D., Gaffal, E., Thaçi, D., & Ludwig, R. J. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf346 · Cited by 22
The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats
Bernosky‐Smith, K. A., Stanger, D. B., Trujillo, A. J., Mitchell, L. R., España, R. A., & Bass, C. E. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.007 · Cited by 21
Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review
Yammine, L., Kosten, T. R., Pimenova, M., & Schmitz, J. M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.033 · Cited by 23
Glucagon-like peptide-1 receptors modulate the binge-like feeding induced by µ-opioid receptor stimulation of the nucleus accumbens in the rat
Pierce-Messick, Z. J., & Pratt, W. E. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001545 · Cited by 22
The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesity
Maejima, Y., Yokota, S., Shimizu, M., Horita, S., Kobayashi, D., Hazama, A., & Shimomura, K. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00582-z · Cited by 21
Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus
Eren, C. Y., Kara, B., Sancak, S., Uysal, S. P., Yazıcı, D., Okuroğlu, N., Whitton, A. E., Rutherford, A. V., & Eser, H. Y. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001409 · Cited by 21
GLP-1-mediated gene therapy approaches for diabetes treatment
Tasyurek, H. M., Altunbaş, H., Canatan, H., Griffith, T. S., & Şanlıoğlu, S. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.7 · Cited by 22
Physiologic and Neural Controls of Eating
Moran, T. H., & Ladenheim, E. E. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.009 · Cited by 22
Neonatal GLP1R activation limits adult adiposity by durably altering hypothalamic architecture
Rozo, A., Babu, D., Suen, P.-M. A., Groff, D., Seeley, R., Simmons, R., Seale, P., Ahima, R., & Stoffers, D. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.006 · Cited by 19
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake
Schalla, M. A., Taché, Y., & Stengel, A. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200007 · Cited by 28
Unravelling the role and mechanism of adipokine and gastrointestinal signals in animal models in the nonhomeostatic control of energy homeostasis: Implications for binge eating disorder
Novelle, M. G., & Diéguez, C. (2018) · European Eating Disorders Review · doi:10.1002/erv.2641 · Cited by 22
Distributed amylin receptor signaling and its influence on motivated behavior
Kern, K. A., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112958 · Cited by 20
Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal
Listos, J., Listos, P., Baranowska‐Bosiacka, I., Karpiuk, A., Filarowska, J., Łupina, M., Słowik, T., Zawiślak, S., & Kotlinska, J. H. (2022) · Molecules · doi:10.3390/molecules27082478 · Cited by 21
Recent Advances in the Neurobiology of Altered Motivation Following Bariatric Surgery
Brutman, J. N., SIROHI, S. K., & Davis, J. F. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1084-2 · Cited by 20
The role of linagliptin, a selective dipeptidyl peptidase-4 inhibitor, in the morphine rewarding effects in rats
Łupina, M., Talarek, S., Kotlinska, J. H., Gibuła‐Tarłowska, E., Listos, P., & Listos, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104616 · Cited by 21
The Food Environment, Preference, and Experience Modulate the Effects of Exendin‐4 on Food Intake and Reward
Mella, R., Schmidt, C. B., Romagnoli, P. P., Teske, J. A., & Perez‐Leighton, C. E. (2017) · Obesity · doi:10.1002/oby.21939 · Cited by 19
Populations of Hindbrain Glucagon-Like Peptide 1 (GLP1) Neurons That Innervate the Hypothalamic PVH, Thalamic PVT, or Limbic Forebrain BST Have Axon Collaterals That Reach All Central Regions Innervated by GLP1 Neurons
Randolph, A. B., Zheng, H., & Rinaman, L. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.2063-23.2024 · Cited by 18
Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study
Tang, H., Lu, Y., Zhang, B., Zhou, T., Zhang, D., Chen, J., Chen, Y., Asch, D. A., & Chen, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70054 · Cited by 24
Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review
Liu, X. D., Chen, X., Wang, C., Song, J., Xu, J., Gao, Z., Huang, Y., & Suo, H. (2024) · Food & Function · doi:10.1039/d3fo04345b · Cited by 19
Acupuncture for obesity and related diseases: Insight for regulating neural circuit
Jiang, L.-Y., Tian, J., Yang, Y., Jia, S., & Shu, Q. (2024) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2024.03.001 · Cited by 19
Exendin-4 antagonizes the metabolic action of acylated ghrelinergic signaling in the hypothalamic paraventricular nucleus
Abtahi, S., Howell, E., Salvucci, J. T., Bastacky, J. M. R., Dunn, D. P., & Currie, P. J. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.10.008 · Cited by 17
Interaction of circulating GLP-1 and the response of the dorsolateral prefrontal cortex to food-cues predicts body weight development
Maurer, L., Mai, K., Krude, H., Haynes, J., Weygandt, M., & Spranger, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.014 · Cited by 19
A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors
Merkel, R., Moreno, A., Zhang, Y., Herman, R. J., Nathan, J. B., Zeb, S., Rahematpura, S., Stecyk, K. S., Milliken, B. T., Hayes, M. R., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.026 · Cited by 17
Self-citation
Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats
Colvin, K. J., Killen, H. S., Kanter, M. J., Halperin, M. C., Engel, L., Dickinson, M., Fimmel, A. I., Holland, J. G., & Currie, P. J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113726 · Cited by 16
Distinctive striatal dopamine signaling after dieting and gastric bypass
Hankir, M. K., Ashrafian, H., Hesse, S., Horstmann, A., & Fenske, W. K. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.005 · Cited by 16
A Novel Use of Liraglutide: Induction of Partial Remission in Ulcerative Colitis and Ankylosing Spondylitis
Jeffrey, L. O. (2019) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410281 · Cited by 17
The tubular striatum and nucleus accumbens distinctly represent reward-taking and reward-seeking
Wright, K. N., & Wesson, D. W. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00495.2020 · Cited by 16
Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review
Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210974 · Cited by 19
The metabolic syndrome in patients with alcohol dependency: Current research and clinical implications
Kahl, K. G., & Hillemacher, T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.05.001 · Cited by 15
Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study
Tsermpini, E. E., Goričar, K., Plesničar, B. K., Ilješ, A. P., & Dolžan, V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.908948 · Cited by 15

Authors: Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Hayes, Matthew R.
ORCID: Alhadeff, Amber L.
Rupprecht, Laura E.
Hayes, Matthew R.
Venue: Endocrinology
Publisher: The Endocrine Society
Published: 2012-02-01
Volume: 153
Issue: 2
Pages: 647-658
ISSN: 0013-7227 (ISSN-L)
1945-7170
DOI: 10.1210/en.2011-1443
PMC: PMC3275387
OpenAlex: W2140625608
Cited by: 515
References: 69
Citations by year: 2026: 66 · 2025: 45 · 2024: 38 · 2023: 26 · 2022: 33 · 2021: 36 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 28 · 2016: 34 · 2015: 31 · 2014: 34 · 2013: 37 · 2012: 13
FWCI: 12.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Endocrinology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: University of Pennsylvania
National Institutes of Health
U.S. Public Health Service (NIDDK 085435)
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK085435)
Topics: Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: glucagon-like peptide-1, GLP-1 receptor, nucleus tractus solitarius, ventral tegmental area, nucleus accumbens, mesolimbic reward system, food intake regulation, body weight, palatable food, monosynaptic projection, hindbrain neurons
MeSH terms: Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, Dose-Response Relationship, Drug, Eating, Gene Expression Regulation, Hypoglycemic Agents, Male, Neurons, Nucleus Accumbens, Peptides, Venoms, Signal Transduction, Rats, Sprague-Dawley, Solitary Nucleus, Ventral Tegmental Area, Receptors, Glucagon, Rats, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks